Michelle Burke

Michelle Burke 

Michelle Burke is a Non-Executive Director for Cell Therapies Pty Ltd, past Chair of AusBiotech Ltd, and a current member of the Pharmaceutical Benefits Advisory Committee.  She also serves as an advisor for Proto Axiom Pty Ltd, an incubator for early stage research commercialisation.  She is a consultant to health-related companies, governments and academia, and a former director at Bristol-Myers Squibb and SmithKline Beecham.


Damien Bolton

Damien Bolton

Professor Damien Bolton is head of Department of Urology and Professor of Surgery at the University of Melbourne Department of Surgery, Austin Health. Damien trained in Melbourne and at the University of California, San Francisco.

He was the first Australian urologist to be awarded the Bard Silver Medal by the British Association of Urologic Surgeons (BAUS), the first urologist recipient of the John Mitchell Crouch Fellowship from the Royal Australasian College of Surgeons, and received the RACS award for excellence in surgical research in 2014. He has published more than 400 peer reviewed manuscripts.

He has served as Chair of the Cancer Council Victoria committee on Urogenital Cancer and co-chair of the Asia-Pacific Prostate Cancer Coalition, as well as on multiple international guidelines committees. He is currently Treasurer of the Societe International d’Urologie based in Montreal Canada and is Vice President of the Urological Society of Australia and New Zealand.


Adam Horsburgh

Adam Horsburgh

Adam currently serves as the Chief Executive Officer of Austin Health.  With extensive health sector management experience in Victoria as well as in the UK National Health Service (NHS).  Adam has held senior policy and advisory roles with the Victorian Government, including the Department of Health (DoH) and the Department of Premier and Cabinet.  Prior to joining Austin Health, Adam was Deputy Chief Executive Officer and Chief Operating Officer at Melbourne Health.  He is also a Director of the Summer Foundation, Florey Institute of Neurosciences and Mental Health, Melbourne Genomics Health Alliance and the Victorian Comprehensive Cancer Centre.


Dr Katherine Woodthorpe AO

Dr Katherine Woodthorpe AO

Dr Katherine Woodthorpe is currently Chair of the State Advisory Committee for the Vision 2040 Strategy of the Australian Government; and President and Chair of the Board of the Academy of Technology and Engineering (ATSE). She is also a Director of Bioplatforms Australia, the Reliable Affordable Clean Energy CRC (RACE 2030), Vast Solar Pty Ltd, and Anteotech Ltd.


Prof John Dewar AO

Prof John Dewar AO

Prof John Dewar AO is the Vice-Chancellor and President of La Trobe University. An internationally-known family law specialist and researcher, he has held senior leadership positions at Griffith University and the University of Melbourne as Provost, and has served on a number of higher education and legal bodies, groups and committees, including for the State and Federal Governments. He is a director of Universities Australia and Adjunct Professor in both the Melbourne and La Trobe Law Schools.


Sally Capp

Sally Capp

The Lord Mayor of Melbourne Sally Capp has extensive experience in executive leadership roles including at the Property Council of Australia, the Victorian Chamber of Commerce, KPMG and ANZ Bank, and represented the Victorian Government as Agent General across Europe and Israel. She has acted on a number of boards including for private and public companies, not-for-profit organisations and was the first female director of the Collingwood Football Club.


Richard Balderstone

Richard Balderstone

Richard Balderstone has worked in the financial and investment markets for over 40 years. He was Chairman and a founding partner of JCP Investment Partners, a specialist funds management organization. Richard is a Trustee Director of several charitable organisations including The Baker Foundation and the Cormack Foundation.


Prof Ashley Dunn

Prof Ashley Dunn

Chair, Scientific Advisory Committee

Prof Ashley Dunn became Head of the Molecular Biology Program at the Ludwig Institute for Cancer Research (Melbourne) in 1982. Two years later he and colleagues molecularly cloned GM-CSF, a cytokine used to aid recovery of bone marrow in cancer patients following chemotherapy treatment.

He served as Associate Director of the Institute until 2004, is currently a Professorial Fellow of the Department of Surgery at the University of Melbourne and serves on several scientific advisory boards.